HVTN Translational HIV Vaccine Early Stage Investigator (ESI) Conference

file


The Nines Hotel

Portland, OR

September 20-21, 2021

The HIV Vaccine Trials Network is proud to announce that it will host the 5th Translational HIV Vaccine Early Stage Investigator Conference, September 20-21, 2021, prior to the NHP AIDS Symposium. 

This conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research. Investigators participating in the conference will gain a sense of their ability to contribute widely to the field and obtain support in reaching career milestones. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations.

This year's conference will be held in person, but plenary sessions will be live-streamed.

To register, click here.
The deadline for registration is August 19, 2021


Target Audience

ESIs who focus on preclinical or clinical HIV vaccine research and are within ten (10) years of completing their terminal research degree, medical residency, or equivalent.


Travel Award

The HVTN will offer a limited number of travel awards to attend this conference. The period for accepting applications has closed. Awardees will be announced shortly.


Program

The program for the 2021 Conference is under development. However, organizers plan to cover the following topics during the Conference:

  • Mucosal and innate immunity
  • Manuscript publication 
  • Grant writing 
  • ESI Works in Progress
  • Impact of new techniques and new technologies on TB
  • Opportunities for working with HVTN


NHP AIDS Symposium

The HVTN Translational ESI Conference will take place prior to the NHP AIDS Symposium, which is being held September 22-24, 2021.  Participation in the NHP Symposium will provide attendees further opportunities to expand their knowledge of HIV vaccine science and to continue to develop professional networks. Information about the NHP AIDS Symposium can be found here.

Contact Information:

For questions, please contact

Alex Berger
Training Project Coordinator
aberge2@hvtn.org

 

 

 

Funding for this conference was made possible in part by 2R13OD024033 from the Office of the Director, National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the National Institutes of Health (NIH); nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government